title: Retained drug-eluting stents and recalcitrant chronic rhinosinusitis: A case report.
abstract: Corticosteroids are the mainstay of treatment for refractory chronic rhinosinusitis. The off-label use of steroid-eluting stents has increasingly gained popularity in functional endoscopic sinus surgery for decreasing postoperative inflammation and synechiae formation. However, there is a paucity of data outlining the safety profile of this device despite its widespread use. This study was designed to report a newly described complication of retained drug-eluting stents from endoscopic sinus surgery for refractory rhinosinusitis. This report highlights a potential risk of the drug-eluting stent in the treatment of recalcitrant rhinosinusitis and the need for further clinical investigations whenever a novel medical device becomes available on the market.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota.
authors.forename: Phayvanh P
authors.initials: PP
authors.lastname: Sjogren
authors.forename: Noah P
authors.initials: NP
authors.lastname: Parker
authors.forename: Holly C
authors.initials: HC
authors.lastname: Boyer
keywords: chronic; complication; corticosteroid; drug eluting; endoscopic sinus surgery; inflammation; polyposis; rhinosinusitis; sinusitis; stent